Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
09/2003
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/17/2003EP1344769A1 Polyol ester derivatives of polyamines and their use as dispersants for lubricating oils
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/17/2003EP1343485A2 Lipid-based nitric oxide donors
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
09/17/2003EP0775127B1 N-alkyl ammonium acetonitrile bleach activators
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443178A (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphtyl] -4-morpholibenzamide
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/17/2003CN1443068A Combinations of depepotidyl peptidase IV inhibitors and other antidiabetic agents for treatment of diabete mellitus
09/17/2003CN1121401C Aminophenol derivates
09/17/2003CN1121400C Synthesis of triethylene diamide and diethylenediamine by using zeolite catalyst modified by silicon contained compound
09/17/2003CN1121385C Haphthyl compounds, intermediates, compositions and methods of use
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620935 Process for producing benzylamine compound
09/16/2003US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
09/16/2003CA2283671C Salt of naphthyridine carboxylic acid derivative
09/16/2003CA2025490C Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
09/13/2003CA2419995A1 New polyol ester derivatives of polyamines and use in turbine oils to improve cleanliness
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2003048081A3 Glycinamides as factor xa inhibitors
09/12/2003WO2002022550A3 Chiral amino alcohols and process for preparation of same
09/11/2003US20030171593 Process for arylating or vinylating or alkynating a nucleophilic compound
09/11/2003US20030171581 Process for the synthesis of morpholinylbenzenes
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171349 Novel muscarinic receptor agonists
09/11/2003US20030171347 Sigma receptor antagonist compounds that have anti-cocaine properties. These sigma receptor antagonists are useful in the treatment of cocaine overdose and addiction as well as movement disorders. The sigma receptor antagonists of the
09/11/2003US20030171210 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/11/2003US20030168192 Novel monomers, polymers thereof and the use of the polymers
09/10/2003EP1341777A2 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatement of incontinence
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1341743A2 Organic reactions with co generating materials
09/10/2003EP1020443B1 Process for producing piperazinesulfonamide derivatives and salts thereof
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003EP0939627B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0809647B1 Chiral organometallic compounds
09/10/2003EP0737067B1 Treatment of hormone-unresponsive metastatic prostate cancer
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441771A Method for producing 3,3-diarylpropylamines
09/10/2003CN1441698A Nickel-rhenium catalyst for use in reductive amination process
09/09/2003US6617454 Process for the preparation of amine oxides
09/09/2003US6617407 Bis(n,n-dihydrocarbylamino)-substituted cyclopentadienes and metal complexes thereof
09/09/2003US6617322 Administering a piperazine or piperidine coupled through a linker to a benzhydril
09/09/2003US6617317 Boronic ester and acid compositions
09/04/2003WO2003072560A1 Triiodine aromatics containing perfluoroalkyl groups and forming micelles, method for their production and their use as contrast media
09/04/2003WO2003072559A1 Method for producing 3-amidinophenylalanine derivatives
09/04/2003WO2003072558A2 Arylsulfone derivatives
09/04/2003WO2003072556A1 Glutaminyl based dpiv inhibitors
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003WO2003072062A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
09/04/2003WO2003072030A2 Methods for preventing or treating cardiac arrhythmia
09/04/2003WO2003045306A3 Phenoxy amine compounds and compositions for delivering active agents
09/04/2003US20030166931 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/04/2003US20030166930 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/04/2003US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166653 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166637 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9H-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
09/04/2003US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
09/04/2003US20030166629 Cyclic quaternary ammonium compounds
09/04/2003US20030166619 N2O2- functionality is bound direct to a carbon atom; treating biological disorders hypertension, restenosis, impotency, genetic disorders or infections
09/04/2003US20030166590 Microsomal triglyceride transfer protein
09/04/2003US20030166578 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
09/04/2003CA2696267A1 Methods for preventing or treating cardiac arrhythmia
09/04/2003CA2479812A1 Glutaminyl based dpiv inhibitors
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/04/2003CA2476173A1 Arylsulfone derivatives
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1340499A1 Nootropic effect enhancer
09/03/2003EP1339702A1 5-amide substituted diarylamines as mek inhibitors
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339684A1 Mch antagonists and their use in the treatment of obesity
09/03/2003EP1339671A2 1,7 and 1,9-diarylpolymethine salts
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1339662A1 Novel estrogen receptor ligands and methods iii
09/03/2003EP1194403B1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
09/03/2003EP1131286B1 Bifunctional photoinitiators suitable for photopolymerization and photopolymerizable systems containing the same
09/03/2003EP1086178B1 An anthraquinone and its derivatives
09/03/2003EP0876359B1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
09/03/2003EP0775689B1 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic